Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Multiple Endocrine Neoplasia Type 2a
0.810 GeneticVariation UNIPROT Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. 27854360 2017
Multiple Endocrine Neoplasia Type 2a
0.810 GeneticVariation UNIPROT A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. 25394175 2015
Multiple Endocrine Neoplasia Type 2a
0.810 GeneticVariation UNIPROT ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. 25356965 2015
Multiple Endocrine Neoplasia Type 2a
0.810 GeneticVariation UNIPROT Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. 24893135 2014
Multiple Endocrine Neoplasia Type 2a
0.810 GeneticVariation UNIPROT ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. 23788249 2013
Multiple Endocrine Neoplasia Type 2a
0.810 GeneticVariation UNIPROT Clinical utility gene card for: multiple endocrine neoplasia type 2. 21863057 2012
Multiple Endocrine Neoplasia Type 2a
0.810 CausalMutation CLINVAR Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. 20979234 2011
Multiple Endocrine Neoplasia Type 2a
0.810 GeneticVariation BEFREE MEN2A (C618S), MEN2A/familial MTC (FMTC) (C620S), and MEN2B (M918T). 22199277 2011
Multiple Endocrine Neoplasia Type 2a
0.810 CausalMutation CLINVAR The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. 20664475 2010
Multiple Endocrine Neoplasia Type 2a
0.810 GeneticVariation UNIPROT Medullary thyroid cancer: management guidelines of the American Thyroid Association. 19469690 2009
Multiple Endocrine Neoplasia Type 2a
0.810 CausalMutation CLINVAR RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest. 19826964 2009
Multiple Endocrine Neoplasia Type 2a
0.810 CausalMutation CLINVAR Mutational spectrum of multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma in taiwan. 19443294 2009
Multiple Endocrine Neoplasia Type 2a
0.810 CausalMutation CLINVAR Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases. 18976013 2008
Multiple Endocrine Neoplasia Type 2a
0.810 GeneticVariation UNIPROT Guidelines for diagnosis and therapy of MEN type 1 and type 2. 11739416 2001
Multiple Endocrine Neoplasia Type 2a
0.810 GeneticVariation CLINVAR The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. 9012462 1997
Multiple Endocrine Neoplasia Type 2a
0.810 CausalMutation CLINVAR Clinical presentations and RET protooncogene mutations in seven multiple endocrine neoplasia type 2 kindreds. 8909322 1996
Multiple Endocrine Neoplasia Type 2a
0.810 GeneticVariation UNIPROT The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. 8918855 1996
Multiple Endocrine Neoplasia Type 2a
0.810 CausalMutation CLINVAR Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests. 7915165 1994
Multiple Endocrine Neoplasia Type 2a
0.810 CausalMutation CLINVAR RET proto-oncogene mutations in French MEN 2A and FMTC families. 7874109 1994
Multiple Endocrine Neoplasia Type 2a
0.810 CausalMutation CLINVAR